Authors:
KRISTMUNDSDOTTIR T
LOFTSSON T
HOLBROOK WP
Citation: T. Kristmundsdottir et al., FORMULATION AND CLINICAL-EVALUATION OF A HYDROCORTISONE SOLUTION FOR THE TREATMENT OF ORAL-DISEASE, International journal of pharmaceutics, 139(1-2), 1996, pp. 63-68
Authors:
KRISTMUNDSDOTTIR T
GUDMUNDSSON OS
INGVARSDOTTIR K
Citation: T. Kristmundsdottir et al., RELEASE OF DILTIAZEM FROM EUDRAGIT MICROPARTICLES PREPARED BY SPRAY-DRYING, International journal of pharmaceutics, 137(2), 1996, pp. 159-165
Authors:
ARNARDOTTIR HB
SVEINSSON SJ
KRISTMUNDSDOTTIR T
Citation: Hb. Arnardottir et al., THE RELEASE OF CLINDAMYCIN PHOSPHATE FROM A SUSPENSION OF DIFFERENT TYPES OF LIPOSOMES AND SELECTED TOPICAL DOSAGES FORMS, International journal of pharmaceutics, 134(1-2), 1996, pp. 71-77
Authors:
UTSUKI T
BREM H
PITHA J
LOFTSSON T
KRISTMUNDSDOTTIR T
TYLER BM
OLIVI A
Citation: T. Utsuki et al., POTENTIATION OF ANTICANCER EFFECTS OF MICROENCAPSULATED CARBOPLATIN BY HYDROXYPROPYL ALPHA-CYCLODEXTRIN, Journal of controlled release, 40(3), 1996, pp. 251-260
Authors:
ARNARDOTTIR HB
SVEINSSON SJ
KRISTMUNDSDOTTIR T
Citation: Hb. Arnardottir et al., THE USE OF A HIGH-INTENSITY ULTRASONIC PROCESSOR EQUIPPED WITH A FLOWCELL IN THE PRODUCTION OF REVERSE-PHASE LIPOSOMES, International journal of pharmaceutics, 117(2), 1995, pp. 237-241
Authors:
KRISTMUNDSDOTTIR T
INGVARSDOTTIR K
SAEMUNDSDOTTIR G
Citation: T. Kristmundsdottir et al., CHITOSAN MATRIX TABLETS - THE INFLUENCE OF EXCIPIENTS ON DRUG-RELEASE, Drug development and industrial pharmacy, 21(13), 1995, pp. 1591-1598
Citation: T. Kristmundsdottir et K. Ingvarsdottir, IBUPROFEN MICROCAPSULES - THE EFFECT OF PRODUCTION VARIABLES ON MICROCAPSULE PROPERTIES, Drug development and industrial pharmacy, 20(5), 1994, pp. 769-778
Authors:
SVEINSSON SJ
KRISTMUNDSDOTTIR T
INGVARSDOTTIR K
Citation: Sj. Sveinsson et al., THE EFFECT OF TABLETTING ON THE RELEASE CHARACTERISTICS OF NAPROXEN AND IBUPROFEN MICROCAPSULES, International journal of pharmaceutics, 92(1-3), 1993, pp. 29-34